Opens in a new tab or window A small panel of circulating biomarkers may reliably distinguish hypertrophic cardiomyopathy ... as well as a 12-lead ECG. The initial comprehensive HCM evaluation ...

Cardiac MRI should be a standard assessment for apical hypertrophic cardiomyopathy (HCM) in athletes with a markedly abnormal ECG, specifically an ECG with deep (>−0.2 mV) TWI and ST segment ...

which collects far more detailed electrical signal data than a routine ECG, could support better identification of high-risk patients with hypertrophic cardiomyopathy. Some people living with ...

Objective Current guidelines recommend precautionary disqualification from competitive sports in patients with hypertrophic cardiomyopathy (HCM ... gender balance, symptoms, ECG abnormalities, extent ...

Hypertrophic cardiomyopathy is the leading etiology worldwide, followed by coronary artery anomalies. Recommendations for pre-participation screening ECG-based pre-participation screening (PPS ...

Technologies announced that the results of the Extended Ambulatory ECG Monitoring Enhances Identification of Higher-Risk ...

2. The AI-powered ECG predicts the likelihood of patients having heart conditions including amyloidosis, atrial fibrillation and hypertrophic cardiomyopathy. 3. A computer vision-based smartphone app ...

An ECG test is non-invasive and can identify ... was diagnosed with a condition known as hypertrophic cardiomyopathy (HCM), which could have had fatal consequences if not detected early.

may create a diagnostic overlap with pathological conditions such as hypertrophic cardiomyopathy. Furthermore, much interest has focused recently on the possibility of irreversible cardiac ...